Skip to content
November 20, 2026
  • Home
  • National News
    • Metro News
      • metro
    • Society
    • Politics
    • Crime and Justice
  • Special Reports
    • Investigation
    • Features
    • Interviews
  • Opinion
    • Business & Economy
    • Commentaries
    • Perspectives
  • Press Releases
  • International News
Political Economist

Political Economist

A liberal News reporting Politics, Sports, Business, Commentaries

  • Home
  • National News
    • Metro News
      • metro
    • Society
    • Politics
    • Crime and Justice
  • Special Reports
    • Investigation
    • Features
    • Interviews
  • Opinion
    • Business & Economy
    • Commentaries
    • Perspectives
  • Press Releases
  • International News
Watch Online
  • Home
  • International News
  • COVID-19: Pfizer Seeks Authorisation For 3rd Shot As Vaccine Efficacy Drops
  • International News

COVID-19: Pfizer Seeks Authorisation For 3rd Shot As Vaccine Efficacy Drops

Admin July 9, 2021
infection

July 9, 2021

Pfizer and BioNTech have announced they would seek regulatory authorization for a third dose of their COVID-19 vaccine.

It comes after initial data from an ongoing trial showed a third shot pushed antibody levels five to 10 times higher against the original coronavirus strain and the Beta variant, first found in South Africa, compared to the first two doses alone, according to a statement.

“The companies expect to publish more definitive data soon as well as in a peer-reviewed journal and plan to submit the data to the FDA (Food and Drug Administration), EMA (European Medicines Agency) and other regulatory authorities in the coming weeks,” the statement said.

In addition, the companies expect that a third dose will perform similarly well against the highly transmissible Delta strain, which is quickly becoming globally dominant.

Out of caution, the companies are also developing a Delta-specific vaccine, the first batch of which has been manufactured at BioNTech’s facility in Mainz, Germany.

The companies anticipate the clinical studies will begin in August, subject to regulatory approvals.

Based on drop-offs in efficacy seen in Israel after six months, the companies said they believe a third dose may be needed within six to 12 months after full vaccination

“While protection against severe disease remained high across the full 6 months, a decline in efficacy against symptomatic disease over time and the continued emergence of variants are expected,” the statement said.

The FDA and US Centers for Disease Control and Prevention released a joint statement late Thursday saying authorities were studying “whether or when a booster might be necessary.”

“Americans who have been fully vaccinated do not need a booster shot at this time,” the agencies said. “We are prepared for booster doses if and when the science demonstrates that they are needed.”

AFP

  • Facebook
  • Share on X
  • LinkedIn
  • WhatsApp
  • Email
  • Copy Link
Tags: BioNTech EMA FDA Pfizer

Post navigation

Previous Pope will lead Sunday prayer from hospital, not well enough to return to the Vatican
Next FG directs NARD, JOHESU to withdraw strike notices

Related Stories

Dozens missing as migrant boat capsizes off Senegal coast, NGO says Migrants
  • International News

Dozens missing as migrant boat capsizes off Senegal coast, NGO says

November 19, 2026
Microsoft outage hits Outlook, Teams and Copilot worldwide Microsoft
  • International News

Microsoft outage hits Outlook, Teams and Copilot worldwide

November 13, 2026
History in New Jersey: Nigerian-Born Lawyer Shirley Emehelu Sworn In as Lieutenant Governor
  • International News

History in New Jersey: Nigerian-Born Lawyer Shirley Emehelu Sworn In as Lieutenant Governor

November 11, 2026
logo

Political Economist is a liberal news magazine with global affiliations.

At Political Economist, we promote free enterprise and act as a catalyst for the growth of knowledge economy. We are proudly pan-Nigeria yet richly spiced with African and global news. We offer a fair and balanced news reportage presented by our team of well-heeled professional journalists. <

About us

  • 5 Olutosin Ajayi Street, By CPM Church, Ajao Estate, Lagos State, Nigeria
  • +234 805 680 1124
  • info@politicaleconomistng.com

You may have missed

Meet Stanley Chiedoziem, the new Managing Director/CEO of Fidelity Bank 
  • Business & Economy

Meet Stanley Chiedoziem, the new Managing Director/CEO of Fidelity Bank 

November 20, 2026
President confers National Honour, GCON, on Wole Olanipekun at his book presentaion
  • National News

President confers National Honour, GCON, on Wole Olanipekun at his book presentaion

November 20, 2026
₦5trn agricultural loss claim is fake news, misleading – Minister
  • Press Releases

₦5trn agricultural loss claim is fake news, misleading – Minister

November 19, 2026
Dozens missing as migrant boat capsizes off Senegal coast, NGO says Migrants
  • International News

Dozens missing as migrant boat capsizes off Senegal coast, NGO says

November 19, 2026
  • Home
  • National News
    • Metro News
      • metro
    • Society
    • Politics
    • Crime and Justice
  • Special Reports
    • Investigation
    • Features
    • Interviews
  • Opinion
    • Business & Economy
    • Commentaries
    • Perspectives
  • Press Releases
  • International News
Copyright © All rights reserved. | DarkNews by AF themes.